Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(15/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(15/week)
News
United States
(534/week)
Manufacturing
(381/week)
Energy
(301/week)
Technology
(425/week)
Other Manufacturing
(319/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Therapix Biosciences Ltd.
Jan 05, 2021
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
Dec 08, 2020
Therapix Biosciences Announces Upgrade to OTCQB Venture Market
Dec 02, 2020
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
Nov 30, 2020
Therapix Biosciences Issues CEO Letter to its Shareholders
Nov 19, 2020
Therapix Biosciences Announces Pricing of $4.2 Million Offering
Aug 21, 2020
Therapix Biosciences Announces Replacement of its Board of Directors
Jul 09, 2020
Therapix Biosciences Announces OTC Pink Ticker Symbol 'TRPXY' and Removal of Injunction by Israeli Court
Jul 01, 2020
Therapix Biosciences Receives Notice of Delisting and Injunction from Israeli Court
Jun 29, 2020
Therapix Biosciences Raises $2.6 Million in Private Placement
May 19, 2020
Therapix Biosciences Closes A Joint Venture Transaction For its Sleep Indication
May 07, 2020
Therapix Biosciences Appoints Prof. Ari Shamiss (M.D., M.P.A.) to the Company's Board of Directors
Apr 28, 2020
Nasdaq Hearings Panel Grants Therapix Biosciences Extension to Regain Compliance With Listing Requirements
Apr 22, 2020
Therapix Biosciences Announces Appointment of New CEO
Apr 01, 2020
Therapix Biosciences Announces Pricing of $1.25 Million Public Offering
Mar 25, 2020
Therapix Biosciences Ltd. Announces Shareholder Conference Call
Mar 19, 2020
Therapix Biosciences Ltd. Signs Securities Purchase Agreement
Feb 27, 2020
Therapix Biosciences Ltd. Receives Nasdaq Notification Regarding Minimum Bid Requirements
Feb 06, 2020
Nasdaq Hearings Panel Grants Therapix Biosciences Extension to Regain Compliance With Listing Requirements
Dec 04, 2019
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
Dec 02, 2019
Therapix Biosciences Announces the Continued Development of THX-210 ("RESPECTRUM") Cannabinoids Based Treatment for Autism Spectrum Disorder
Page 1
››
Latest News
May 1, 2024
Valaris Issues Fleet Status Report
May 1, 2024
Kolibri Global Energy Inc. Provides Update on 2023 Annual Filings
May 1, 2024
Leeward Renewable Energy Operations Announces the Posting of Year End 2023 Financial Results and May 10...
May 1, 2024
Itron Enhances Temetra® Platform to Maximize Business Value for Water Utilities in Australia and New Zealand
May 1, 2024
Imperial reports voting results for election of directors
May 1, 2024
Microvast Schedules First Quarter Earnings Call
May 1, 2024
Magellan Aerospace Announces Quarterly Dividend
May 1, 2024
Magellan Aerospace Announces Report on Voting Results for Directors
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events